The primary consideration for extended use is whether the therapeutic goal tissue repair, metabolic optimization has been achieved, or whether ongoing use serves a maintenance function
thus, more objective evidence is needed to support their conclusions
Peptides: Tesamorelin, AOD9604, Tirzepatide (GLP-1 agonist) Tesamorelin is FDA-approved to reduce visceral adipose tissue (VAT) in HIV-associated lipodystrophy, but its fat-burning effects also appear in non-HIV populations AOD9604 is a modified fragment of human GH (176191) shown in animal and early human trials to enhance lipolysis without altering blood sugar or cortisol Tirzepatide , while technically a GLP-1/GIP agonist , is now frequently stacked with peptides in clinical practice to accelerate fat loss and appetite control
Our team will discuss potential side effects and how to manage them during your consultation
These ingredients work together to support your energy and endurance, promoting overall well-being